2 research outputs found

    Anaphylactic Shock A Form of Distributive Shock without Inhibition of Oxygen Consumption

    Get PDF
    Background: The pathophysiology of anaphylactic shock during anesthesia is incompletely characterized. It is described as distributive by analogy with septic shock (anaerobic metabolism, high tissue oxygen pressure [PtiO 2 ] values). The PtiO 2 profile and its metabolic consequences during anaphylaxis are not known. Methods: Ovalbumin-sensitized anaphylactic shock rats (n ‫؍‬ 11) were compared to nicardipine-induced hypotension rats (n ‫؍‬ 12) for systemic hemodynamics, PtiO 2 , sympathetic nervous system activation, skeletal muscle blood flow, and interstitial lactate and pyruvate concentrations using combined microdialysis and polarographic Clark-type oxygen probes. Results: In both groups, the time course and the magnitude of arterial hypotension were similar. The ovalbumin group but not the nicardipine group displayed decreased skeletal muscle blood flow (from 45 ؎ 6.2 ml ⅐ 100 g ؊1 ⅐ min ؊1 to 24.3

    Comparison of Arginine Vasopressin, Terlipressin, or Epinephrine to Correct Hypotension in a Model of Anaphylactic Shock in Anesthetized Brown Norway Rats

    No full text
    Background: Arginine vasopressin (AVP) and terlipressin were proposed as alternatives to catecholamines in shock states characterized by decreased plasma AVP concentrations. The endogenous plasma AVP profile in anaphylactic shock is unknown. In an ovalbumin-sensitized anesthetized anaphylactic shock rat model, the authors investigated (1) plasma AVP concentrations and (2) the dose versus mean arterial pressure response for exogenous AVP and terlipressin and compared them with those of epinephrine. Methods: In a first series of rats (n ‫؍‬ 12), endogenous plasma AVP concentrations were compared with a model of pharmacologically induced hypotension (nicardipine, n ‫؍‬ 12). A second series was randomly assigned to three groups (AVP, n ‫؍‬ 7; terlipressin, n ‫؍‬ 7; epinephrine, n ‫؍‬ 7) and dose (AVP: 8 doses, 0.03-100 U/kg; terlipressin: 7 doses, 0.03-30 g/kg; epinephrine: 7 doses, 0.3-300 g/kg)-response mean arterial pressure curves were plotted. Data are expressed as mean ؎ SD. Results: Endogenous plasma AVP concentrations were significantly lower in anaphylactic shock (57 ؎ 26 pg/ml) than in the nicardipine group (91 ؎ 43 pg/ml; P < 0.05). The ED 50 was 10.6 g/kg (95% confidence interval, 7.1-15.9) for epinephrine and 4.1 U/kg (95% confidence interval, 3.0 -5.6) for AVP. Terlipressin did not change mean arterial pressure, regardless of the dose used. Conclusions: In a rat model, anaphylactic shock is associated with inadequately low plasma AVP concentrations. For clinically relevant doses, AVP and epinephrine had comparable effects on mean arterial pressure and heart rate values, whereas, unexpectedly, terlipressin was ineffective. These results are consistent with reports in humans experiencing anaphylaxis where AVP injection restored arterial pressure
    corecore